{"a":[{"_":"Chutes & Ladders—Neumora shuffles leadership ahead of IND","$":{"href":"/biotech/chutes-ladders-neumora-shuffles-leadership-ahead-ind","hreflang":"en"}}]}

Neutral

AI Analysis

Summary

Neumora Therapeutics appoints Joshua Pinto as chief executive officer. The clinical-stage biotech is preparing for an IND filing with assets targeting obesity and neurological indications.

Importance:3/10

Sentiment:

0.00

leadershipmanagementINDobesityneurology

Read the original article

Published by FierceBiotech on August 20, 2026 3:03 PM

Read Original